glp-1 maintenance Long Term Use: and Offboarding GLP-1 Maintenance: A Clear Guide

The SELECT trial and subsequent renal subgroup analyses suggested that, in populations with both obesity and pre-existing cardiovascular disease, semaglutide not only reduced the risk of cardiovascular events but also slowed the decline of the estimated glomerular filtration rate (eGFR) ( As indications have expanded from diabetes to obesity, GLP-1RAs have increasingly entered routine care for women of reproductive age, including those with PCOS, in whom obesity and insulin resistance are highly prevalent ( 1.4 Rationalizing fertility-centered review of GLP-1RAs in PCOS: bridging metabolic-reproductive divide 1.4.1 Clinical paradox: tension between metabolic optimization and reproductive urgency While GLP-1RAs have been established as a first-line intervention for managing metabolic comorbidities in PCOS, their potential teratogenic risks and the requirement for strict preconception washout periods present a formidable clinical dilemma for reproductive specialists

All combination groups that included DAPA achieved suppression of this effect

"The most notable benefits of GLP-1 receptor agonists for patients with diabetes or obesity are their ability to promote significant weight loss, reduction in appetite, and improvement in blood sugar control," says Dr

Do not expect anything dramatic in the first week